Robert Hopfner
@Pivotal Bioventure Partners Investment Advisor Llc
Latest period2024 - Q3ReportedManaged Assets$168.472MTotal holdings11
Assets growth rate29.53%Assets growth rate (2-Q avg)6.57%Continuous growth in asset value1 quarters
Portfolio positions
This chart displays the top 10 holdings in Pivotal Bioventure Partners Investment Advisor Llc's 2024 - Q3 portfolio, based on their 13F SEC filing, out of a total of 11 positions.
Assets under management
The assets under management (AUM) of Pivotal Bioventure Partners Investment Advisor Llc over the past 10 years (40 quarters) show continuous growth in total asset value over the last 1 quarters. As of the latest 13F SEC filing for 2024 - Q3, they manage 168.472M in assets, with a quarterly growth rate of 29.53% and a 2-quarter average growth rate of 6.57%. The portfolio is managed by Robert Hopfner, and others.
Portfolio holdings
Investment | Portfolio % | Reported Value | Recent Activity |
---|---|---|---|
PCVXVaxcyte Inc
| 43.38% | $73.08M 639,539 shares@ $114.28 avg price | Decreased -19.35% |
INZYInozyme Pharma Inc
| 13.96% | $23.508M 4.495M shares@ $5.24 avg price | |
ARQTArcutis Biotherapeutics Inc
| 11.71% | $19.721M 2.121M shares@ $9.31 avg price | Increased 3.9% |
OCSOculis Holding Ag
| 11.62% | $19.566M 1.596M shares@ $12.27 avg price | |
ZBIOZenas Biopharma Inc
| 6.54% | $11.01M 650,695 shares@ $16.92 avg price | New Position |
BIOABioage Labs Inc
| 6.52% | $10.975M 527,647 shares@ $20.81 avg price | New Position |
EXAIExscientia Plc
| 2.24% | $3.76M 770,500 shares@ $4.88 avg price | |
RLYBRallybio Corp
| 1.67% | $2.813M 2.405M shares@ $1.17 avg price | |
VIGLVigil Neuroscience Inc
| 1.14% | $1.906M 560,595 shares@ $3.4 avg price | |
BOLTBolt Biotherapeutics Inc
| 0.73% | $1.226M 1.891M shares@ $0.65 avg price |